• Executive summary
  • 1. Introduction
  • 2. Mandate and project outline
  • 3. Conceptual clarifications
  • a. About Treatment, Harm Reduction and Prevention
  • b. About Best Practice, Quality Standards and Guidelines
  • c. A quality concept for drug demand reduction
  • 4. Methodology
  • a. National and international project partners
  • b. Methodology used for drug treatment and harm reduction
  • c. Methodology used for prevention standards
  • 5. Consensus building process in the EU
  • a. Expert seminars
  • b. Stakeholder surveys
  • c. European conference of stakeholders
  • d. Stakeholder comments on the proposed standards
  • 6. Proposed Lists of Minimum Quality Standards
  • a. Prevention standards
  • b. Treatment/rehabilitation standards
  • c. Harm reduction standards
  • 7. Implementation of standards at national level
  • a. Data on acceptability of proposed standards
  • b. Data on expected implementation problems
  • c. Lessons from models of implementation
  • 8. Ideas for further research and follow-up projects
  • a. Missing Information: a gap analysis
  • b. Proposals for an extended consensus building process
  • c. Moving from proposed lists to international implementation guidelines
  • d. Monitoring and evaluating the implementation process
  • 9. References, tables, technical terms, abbreviations
  • 10. Annexes to the report
  • 10.1 List of experts involved as project partners
  • 10.2 List of steering group members
  • 10.3 First interim report
  • 10.4 Instructions for document search and transmission
  • 10.5 List of templates treatment/rehabilitation and harm reduction
  • 10.6 Inventory of quality standards
  • 10.7 Correspondence of EQUS prevention standards and European drug prevention quality standards
  • 10.8 Minutes of first expert seminar
  • 10.9 Minutes of second expert seminar
  • 10.10 Second interim report
  • 10.11 List of conference partparticipants
  • 10.12 Conference working paper
  • 10.13 Conference report
  • 10.14 Questionnaire for on-line stakeholder survey
Persistent link: https://www.econbiz.de/10010528007